Cargando…
(18)F-Fluorodihydroxyphenylalanine vs other radiopharmaceuticals for imaging neuroendocrine tumours according to their type
6-Fluoro-((18)F)-L-3,4-dihydroxyphenylalanine (FDOPA) is an amino acid analogue for positron emission tomography (PET) imaging which has been registered since 2006 in several European Union (EU) countries and by several pharmaceutical firms. Neuroendocrine tumour (NET) imaging is part of its registe...
Autores principales: | Balogova, Sona, Talbot, Jean-Noël, Nataf, Valérie, Michaud, Laure, Huchet, Virginie, Kerrou, Khaldoun, Montravers, Françoise |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer-Verlag
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3644207/ https://www.ncbi.nlm.nih.gov/pubmed/23417499 http://dx.doi.org/10.1007/s00259-013-2342-x |
Ejemplares similares
-
Incidental uptake of (18)F-fluorocholine (FCH) in the head or in the neck of patients with prostate cancer
por: Hodolic, Marina, et al.
Publicado: (2014) -
Consequence of the introduction of routine FCH PET/CT imaging for patients with prostate cancer: a dual centre survey
por: Hodolic, Marina, et al.
Publicado: (2014) -
A Pilot Comparison of (18)F-fluorocholine PET/CT, Ultrasonography and (123)I/(99m)Tc-sestaMIBI Dual-Phase Dual-Isotope Scintigraphy in the Preoperative Localization of Hyperfunctioning Parathyroid Glands in Primary or Secondary Hyperparathyroidism: Influence of Thyroid Anomalies
por: Michaud, Laure, et al.
Publicado: (2015) -
Fluorine-18-fluorodihydroxyphenylalanine Positron-emission Tomography Scans of Neuroendocrine Tumors (Carcinoids and Pheochromocytomas)
por: Zanzi, Italo, et al.
Publicado: (2017) -
(18)F-fluorocholine PET/CT in patients with occult biochemical recurrence of prostate cancer: Detection rate, impact on management and adequacy of impact. A prospective multicentre study
por: Gillebert, Quentin, et al.
Publicado: (2018)